本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Mereo Biopharma Group Plc

0.3291
-0.0098-2.89%
盤後0.3180-0.0111-3.37%19:54 EDT
成交量:144.59萬
成交額:47.25萬
市值:5,237.02萬
市盈率:-1.25
高:0.3360
開:0.3360
低:0.3200
收:0.3389
52周最高:3.05
52周最低:0.2000
股本:1.59億
流通股本:1.00億
量比:1.10
換手率:1.44%
股息:- -
股息率:- -
每股收益(TTM):-0.2629
每股收益(LYR):-0.2627
淨資產收益率:-82.21%
總資產收益率:-39.41%
市淨率:1.28
市盈率(LYR):-1.25

資料載入中...

2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/17

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/14

重要事件披露

Form 8-K - Current report